Last update: May 21, 2024 01:11

Newsroom logo

Azerbaijan to Stage First Overseas Trials of Turkish Covid-19 Vaccine

By Ilham Karimli March 5, 2022


The phase three studies of Turkiye's locally made Turkovac vaccine against Covid-19 proved it to be at least as effective as the Chinese CoronaVac / Courtesy

The first overseas trials of the Turkovac vaccine against Covid-19 will be held in Azerbaijan next week, Healthcare Minister of Turkiye Fahrettin Koca said this week.

According to Koca, all preparations for the third testing phase have been completed in Azerbaijan.

“Last week, we started using Turkovac in all our hospitals,” quoted Koca as saying

“Currently, the number of Turkovac vaccines has exceeded one million, and their production is increasing day by day. I think that in two months, we will easily reach 1-1.5 million per month,” he added.

According to data compiled by the Turkish government, the national vaccine is being used in all 81 provinces of Turkiye. 

The phase one trials of Turkovac started in November 2020, with the second and third phases have been rolled out in February and June 2021, respectively. The phase three studies proved the vaccine to be at least as effective as Chinese CoronaVac, the efficacy of which is said to be 100 percent against severe Covid-19. 

Officials at the Turkish Vaccine Institute confirmed Turkovac to fight the Omicron variant effectively.

Meanwhile, more than 13 million doses of vaccines have been administered in Azerbaijan since the start of the mass vaccination in January 2021. Over 5.3 million people have received the first dose, while nearly 4.8 million people - the second dose. In addition, around 2.8 million people have been given a booster shot.

Azerbaijan’s health authorities have so far authorized Chinese CoronaVac, German-American Pfizer BioNTech, Russian Sputnik V, and British-Swedish Vaxzevria (formerly AstraZeneca). The CoronaVac vaccine accounts for the largest number of vaccines used against Covid-19 in the country. 

The ongoing voluntary and state-sponsored vaccination in Azerbaijan is scheduled for 2021-2022. Those who received two shots of a vaccine are eligible to receive a “vaccination certificate.” At the same time, those who have contracted the virus and fought it off can obtain an “immune certificate.”

Starting on February 15, 2022, the vaccination certificate is considered valid for six months after the second-dose completion. Earlier, the certificates were issued permanently.

According to the latest data, Covid-19 infected nearly 789,000 people in Azerbaijan, of which more than 774,000 recovered. The virus claimed 9,500 lives in the country of ten million population.